Research Summaries

Vaccination
Vaccination
07/14/2022
Researchers examined the relationship between influenza vaccination and the development of Alzheimer disease in older US adults.
07/14/2022
Gastrointestinal Disorders
Gastrointestinal Disorders
05/24/2021
In a recent study, researchers investigated the association between rates of Alzheimer disease and inflammatory bowel disease.
05/24/2021
Treatment
Treatment
03/15/2021
The authors of a recent study aimed to examine if the antibody donanemab could improve Alzheimer disease by targeting amyloid deposits.
03/15/2021
Nutrition
Nutrition
09/02/2020
In a recent pilot study, researchers investigated the influence that particular diets and the gut microbiome have on Alzheimer disease markers and mild cognitive impairment.
09/02/2020
Screening
Screening
07/29/2020
New data presented at the Alzheimer’s Association International Conference indicate that measuring levels of this biomarker in plasma and cerebrospinal fluid can detect Alzheimer disease with high...
07/29/2020
Memory Disorders
Memory Disorders
07/29/2020
In a study of nearly 1.5 million people, researchers aimed to determine the impact of infections on the risk of mortality among people with or without dementia. The findings were presented at the...
07/29/2020
Vaccination
Vaccination
07/29/2020
Influenza vaccination may be a “promising, readily available candidate” for the prevention of Alzheimer disease, according to new findings presented at the Alzheimer’s Association International Conference. ...
07/29/2020
Vaccination
Vaccination
07/28/2020
Data from 3 studies presented at the 2020 Alzheimer’s Association International Conference suggest that vaccination against influenza and pneumonia is associated with a reduction in the risk of Alzheimer...
07/28/2020
Dementia
Dementia
07/08/2020
Despite known, independent associations of hearing loss and vision loss with dementia, less is known about the relationship between dual sensory impairment and dementia risk. Researchers aimed to assess...
07/08/2020
FDA
FDA
05/29/2020
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
05/29/2020